chr17-64496464-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_007215.4(POLG2):​c.505G>A​(p.Ala169Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.127 in 1,601,182 control chromosomes in the GnomAD database, including 27,966 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 11392 hom., cov: 32)
Exomes 𝑓: 0.11 ( 16574 hom. )

Consequence

POLG2
NM_007215.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.252
Variant links:
Genes affected
POLG2 (HGNC:9180): (DNA polymerase gamma 2, accessory subunit) This gene encodes the processivity subunit of the mitochondrial DNA polymerase gamma. The encoded protein forms a heterotrimer containing one catalytic subunit and two processivity subunits. This protein enhances DNA binding and promotes processive DNA synthesis. Mutations in this gene result in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions.[provided by RefSeq, Sep 2009]
MILR1 (HGNC:27570): (mast cell immunoglobulin like receptor 1) Predicted to enable transmembrane signaling receptor activity. Predicted to be involved in several processes, including cell-cell adhesion via plasma-membrane adhesion molecules; mast cell degranulation; and negative regulation of mast cell activation. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.0777327E-6).
BP6
Variant 17-64496464-C-T is Benign according to our data. Variant chr17-64496464-C-T is described in ClinVar as [Benign]. Clinvar id is 138782.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-64496464-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.697 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POLG2NM_007215.4 linkuse as main transcriptc.505G>A p.Ala169Thr missense_variant 1/8 ENST00000539111.7 NP_009146.2 Q9UHN1E5KS15

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POLG2ENST00000539111.7 linkuse as main transcriptc.505G>A p.Ala169Thr missense_variant 1/81 NM_007215.4 ENSP00000442563.2 Q9UHN1

Frequencies

GnomAD3 genomes
AF:
0.278
AC:
42248
AN:
151940
Hom.:
11356
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.703
Gnomad AMI
AF:
0.0855
Gnomad AMR
AF:
0.245
Gnomad ASJ
AF:
0.102
Gnomad EAS
AF:
0.0333
Gnomad SAS
AF:
0.110
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.0969
Gnomad OTH
AF:
0.221
GnomAD3 exomes
AF:
0.151
AC:
37805
AN:
250614
Hom.:
6054
AF XY:
0.137
AC XY:
18509
AN XY:
135504
show subpopulations
Gnomad AFR exome
AF:
0.724
Gnomad AMR exome
AF:
0.205
Gnomad ASJ exome
AF:
0.101
Gnomad EAS exome
AF:
0.0314
Gnomad SAS exome
AF:
0.115
Gnomad FIN exome
AF:
0.114
Gnomad NFE exome
AF:
0.0941
Gnomad OTH exome
AF:
0.122
GnomAD4 exome
AF:
0.111
AC:
160226
AN:
1449124
Hom.:
16574
Cov.:
31
AF XY:
0.109
AC XY:
78259
AN XY:
718206
show subpopulations
Gnomad4 AFR exome
AF:
0.729
Gnomad4 AMR exome
AF:
0.209
Gnomad4 ASJ exome
AF:
0.102
Gnomad4 EAS exome
AF:
0.0354
Gnomad4 SAS exome
AF:
0.118
Gnomad4 FIN exome
AF:
0.116
Gnomad4 NFE exome
AF:
0.0889
Gnomad4 OTH exome
AF:
0.130
GnomAD4 genome
AF:
0.278
AC:
42332
AN:
152058
Hom.:
11392
Cov.:
32
AF XY:
0.276
AC XY:
20486
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.704
Gnomad4 AMR
AF:
0.245
Gnomad4 ASJ
AF:
0.102
Gnomad4 EAS
AF:
0.0332
Gnomad4 SAS
AF:
0.109
Gnomad4 FIN
AF:
0.115
Gnomad4 NFE
AF:
0.0969
Gnomad4 OTH
AF:
0.219
Alfa
AF:
0.126
Hom.:
5614
Bravo
AF:
0.305
TwinsUK
AF:
0.0871
AC:
323
ALSPAC
AF:
0.0841
AC:
324
ESP6500AA
AF:
0.686
AC:
3023
ESP6500EA
AF:
0.0962
AC:
827
ExAC
AF:
0.157
AC:
19094
Asia WGS
AF:
0.111
AC:
388
AN:
3478
EpiCase
AF:
0.0952
EpiControl
AF:
0.0980

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 30, 2011This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicFeb 22, 2016- -
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Mitochondrial dna depletion syndrome 16B (neuroophthalmic type) Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Mitochondrial DNA depletion syndrome 16 (hepatic type) Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
15
DANN
Benign
0.94
DEOGEN2
Benign
0.0072
T
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.071
N
LIST_S2
Benign
0.54
T
MetaRNN
Benign
0.0000021
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.8
L
PrimateAI
Benign
0.36
T
PROVEAN
Benign
0.93
N
REVEL
Benign
0.16
Sift
Benign
0.44
T
Sift4G
Benign
0.58
T
Polyphen
0.0060
B
Vest4
0.023
MPC
0.13
ClinPred
0.0028
T
GERP RS
1.6
Varity_R
0.026
gMVP
0.099

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1427463; hg19: chr17-62492582; COSMIC: COSV56749110; COSMIC: COSV56749110; API